These observations were further supported in a cell model of endogenous stabilization of HIF-1α, RCC4 clear cell renal cell carcinoma (CCRCC), which harbor an inactivating mutation in VHL, thereby preventing degradation of endogenous HIF-1α in normoxic conditions27. This evidence concerns the gene HIF1A and clear cell renal carcinoma.